Saltar al contenido
PivotalWire

Empresas›CGC

CGC · Canopy Growth Corp

quimica medicinal · CIK 0001737927

Caja
no publicable
faltan datos o hay una emision posterior a la ultima cifra de caja conocida
Dilucion
sin datos
hacen falta dos recuentos de acciones
Ultimo documento
7 ago 2026
Hecho relevante

Documentos presentados ante la SEC

2026

  1. 8-KHecho relevanteEDGAR
  2. ARSInforme anual para accionistasEDGAR
  3. DEFA14AMaterial adicional para la junta de accionistasEDGAR
  4. 10-QInforme trimestralEDGAR
    Debilidad material en el control interno…eakness. As previously disclosed in Item 9A of the Annual Report, we previously identified a material weakness in our internal control over financial reporting related to incorrect non-cash…
    Programa de venta continua de acciones (ATM)…e “Exchangeable Shares”). (i) Equity financings On August 29, 2025, the Company established a new at-the-market equity program (the “August 2025 ATM Program”) that allows it to issue and sell up to US$200,0…
  5. 8-KHecho relevanteEDGAR
    Duda sustancial sobre la continuidad de la empresa…operations and requires additional capital to fund its operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The Company concluded that the substantial doubt raised about the Company’s ab…
  6. DEF 14AConvocatoria de junta de accionistasEDGAR
    Duda sustancial sobre la continuidad de la empresa…operations and requires additional capital to fund its operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The Company concluded that the substantial doubt raised about the Company’s ab…
  7. PRE 14AConvocatoria de junta (borrador)EDGAR
  8. 4Operacion de un directivo o accionista significativoEDGAR
  9. 4Operacion de un directivo o accionista significativoEDGAR
  10. 4Operacion de un directivo o accionista significativoEDGAR
  11. 4Operacion de un directivo o accionista significativoEDGAR